Valdrè L - Search Results

1

Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets.

Catani L, Vianelli N, Luatti S, Rizzi S, Castellani S, Valdrè L, Lemoli RM, Tura S. Catani L, et al. Among authors: valdre l. Bone Marrow Transplant. 1999 Dec;24(11):1191-4. doi: 10.1038/sj.bmt.1702062. Bone Marrow Transplant. 1999. PMID: 10642807 Clinical Trial.

2

Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura.

Vianelli N, Tazzari PL, Baravelli S, Ricci F, Valdrè L, Tura S. Vianelli N, et al. Among authors: valdre l. Haematologica. 1998 Aug;83(8):761-3. Haematologica. 1998. PMID: 9793270

3

Recombinant human tissue plasminogen activator without heparin is effective in the treatment of hepatic veno-occlusive disease.

Gherlinzoni F, Vianelli N, Valdrè L, Catani L, Tani M, Tura S. Gherlinzoni F, et al. Among authors: valdre l. Haematologica. 1999 Feb;84(2):191-2. Haematologica. 1999. PMID: 10091426 Clinical Trial. No abstract available.

4

Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients.

Vianelli N, Valdrè L, Fiacchini M, de Vivo A, Gugliotta L, Catani L, Lemoli RM, Poli M, Tura S. Vianelli N, et al. Among authors: valdre l. Haematologica. 2001 May;86(5):504-9. Haematologica. 2001. PMID: 11410414

5

Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines.

Catani L, Amabile M, Luatti S, Valdrè L, Vianelli N, Martinelli G, Tura S. Catani L, et al. Among authors: valdre l. Stem Cells. 2001;19(4):339-47. doi: 10.1634/stemcells.19-4-339. Stem Cells. 2001. PMID: 11463954

6

Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis.

Catani L, Vianelli N, Amabile M, Pattacini L, Valdrè L, Fagioli ME, Poli M, Gugliotta L, Moi P, Marini MG, Martinelli G, Tura S, Baccarani M. Catani L, et al. Among authors: valdre l. Leukemia. 2002 Sep;16(9):1773-81. doi: 10.1038/sj.leu.2402597. Leukemia. 2002. PMID: 12200693

7

Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.

Cavo M, Zamagni E, Cellini C, Tosi P, Cangini D, Cini M, Valdrè L, Palareti G, Masini L, Tura S, Baccarani M. Cavo M, et al. Among authors: valdre l. Blood. 2002 Sep 15;100(6):2272-3. doi: 10.1182/blood-2002-06-1674. Blood. 2002. PMID: 12229885 Free article. No abstract available.

8

Prevention of VTE in multiple myeloma patients.

Zamagni E, Valdrè L, Palareti G, Cavo M. Zamagni E, et al. Among authors: valdre l. Thromb Res. 2007;120 Suppl 2:S133-6. doi: 10.1016/S0049-3848(07)70142-1. Thromb Res. 2007. PMID: 18023708 No abstract available.

9

Real-world experience of rIX-FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy - Results from IDEAL Part B.

Coppola A, Peyvandi F, Banov L, Cultrera D, Margaglione M, Tosetto A, Valdrè L, Schiavetti I, Loraschi A, Castaman G; Ideal Study Group. Coppola A, et al. Among authors: valdre l. Haemophilia. 2024 Jul;30(4):1067-1070. doi: 10.1111/hae.15074. Epub 2024 Jun 20. Haemophilia. 2024. PMID: 39014893 No abstract available.

10

Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.

Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, Coccheri S. Palareti G, et al. Among authors: valdre l. Circulation. 2003 Jul 22;108(3):313-8. doi: 10.1161/01.CIR.0000079162.69615.0F. Epub 2003 Jul 7. Circulation. 2003. PMID: 12847064 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters